Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.27 USD | -1.37% | -6.50% | -24.35% |
Sales 2024 * | 599M 49.99B | Sales 2025 * | 767M 64B | Capitalization | 5.58B 466B |
---|---|---|---|---|---|
Net income 2024 * | -575M -48B | Net income 2025 * | -518M -43.24B | EV / Sales 2024 * | 8.37 x |
Net cash position 2024 * | 567M 47.33B | Net Debt 2025 * | 318M 26.55B | EV / Sales 2025 * | 7.69 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-11.5
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.13% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -1.37% | ||
1 week | -6.50% | ||
Current month | -7.25% | ||
1 month | -8.31% | ||
3 months | -22.01% | ||
6 months | -22.14% | ||
Current year | -24.35% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 01/12/01 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 01/00/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 03/14/03 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Joan Herman
BRD | Director/Board Member | 70 | 10/19/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 38.27 | -1.37% | 983,112 |
13/24/13 | 38.8 | -0.72% | 1,045,266 |
10/24/10 | 39.08 | -0.99% | 895,065 |
09/24/09 | 39.47 | -1.72% | 1,300,598 |
08/24/08 | 40.16 | -1.88% | 1,527,136 |
Delayed Quote Nasdaq, May 15, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.35% | 5.58B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- IONS Stock